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A report of BioSysBio 2009, the IET conference on Synthetic
Biology, Systems Biology and Bioinformatics, Cambridge, UK,
23-25 March 2009.
The fourth meeting in the BioSysBio conference series
brought together international researchers in the interacting
disciplines of synthetic biology, systems biology and bio-
informatics. This conference was largely student-run, and as
well as the formal talks included workshops, discussion
sessions and a panel session on ethics, public engagement
and biosecurity. A wide range of topics was covered at the
conference, including modeling, biofuels and environmental
bioremediation, metabolomics, structural and computational
genomics, and software tools. Of note were the number of
groups presenting improved models of metabolism, studying
cellular subsystems such as cell death and circadian rhythms.
Others are developing new approaches and standards for
systems and synthetic biology, and significant improvements
were reported for Systems Biology Markup Language (SBML)
and the MIT Registry of Standard Biological Parts. A few
highlights of the meeting are given here.
S Sy yn nt th he et ti ic c   b bi io ol lo og gy y   a an nd d   i it ts s   s st ta an nd da ar rd di iz za at ti io on n
Synthetic biology is a newly emerging field, where biological
components are reengineered to provide new, designed
functions. In a keynote lecture, Adam Arkin (University of
California, Berkeley, USA) discussed the origins of synthetic
biology and its scalability, as well as the engineering
challenges that lie beyond the bioreactor. In his view, using
synthetic biology, whether to meet an engineering or
biological challenge, can be transparent, efficient, reliable,
predictable and safe, unlike other human interventions such
as selective breeding and the introduction of non-native
species. Arkin also described ways of reducing the time and
improving the reliability of biosynthesis, such as the use of
standardized parts, computer-assisted design, and methods
for quickly assembling parts. Evolved systems are complex
and subtle, and he highlighted the fact that synthetic
organisms need to deal with the same uncertainty and
competition as do existing organisms.
Among the ‘parts’ required in synthetic biology are switches
that can function, for example, as regulators of gene
expression. Christina Smolke (Stanford University, USA)
presented novel design strategies for constructing RNA-
based molecular switches that can function as both bio-
sensors and ligand-controlled regulators of gene expression.
Binding of the appropriate ligand leads to a regulated
conformational change in a designed RNA molecule, which
in turn can be linked to an appropriate readout signal,
enabling these molecules to act as sophisticated cellular
biosensors. She also described how such riboswitches can be
used as targeted or ‘intelligent’ therapeutic molecules for
treatment of cancer, allowing them to be carefully tuned to
respond as a precise set of molecular stimuli.
Given the recent explosion in the number of approaches to
synthetic biology and the amount of data at the interface of
genomic and systems biology, there is now an over-whelming
need to organize these data efficiently in appropriate reposi-
tories. An update on current standards for DNA description
by Guy Cochrane (EBI, Cambridge, UK) focused on the
different raw sequencing formats available and, in
particular, the work that is being done at EMBL to integrate
them, via SRS. In an overview of standards and improve-
ments in SBML language, which is the platform for most
software in systems biology, Herbert Sauro (University of
Washington, Seattle, USA) emphasized the need toincorporate multi-compartment models into the existing
framework of SMBL. Randy Rettberg (Massachusetts
Institute of Technology, Cambridge, USA) provided an
overview of the publicly available synthetic biology repository
being developed at MIT
[http://partsregistry.org/Main_Page] as a result of contri-
butions from participants in iGEM - the international
genetically engineered machine competition.
S Sy ys st te em ms s   b bi io ol lo og gy y   a an nd d   a au ut to om ma at ti io on n
Because of the complexity of biological systems, it has
always been a challenge to develop predictive dynamic
models that are sensitive to changes in biological inputs, but
at the same time robust to technical noises. A variety of
approaches were described at the meeting. Using a Bayesian
framework to study the inferability of model parameters
under experimental noise, Kamil Erguler (Imperial College
London, UK) introduced sensitivity profiles to identify the
relative impacts of changes in parameters on the global
dynamics of biochemical models. This analysis revealed the
degree of robustness of inferences drawn from different
parts of biochemical pathways and thus provides a guide to
improved data collection. Andre Ribeiro (Tampere
University of Technology, Finland) has developed a delayed
stochastic model to investigate the stepwise elongation
motion of RNA polymerase and its pauses during
transcription. He showed that transcriptional noise level was
affected by the durations of the pauses, which could in turn
be intrinsically encoded within the DNA sequence.
Another challenge is to store all the information being
generated by all the -omic sciences. Catherine Lloyd
(Auckland Bioengineering Institute, New Zealand) described
the language CellML, which is written in XML and uses
existing formats such as MathML and RDF to describe
biological models of cellular function. The CellML model
repository has over 380 models, free to download
[http://www.cellml.org/]. CellML has a number of other
useful features, including modularity and the sharing of
components such as entities and processes. Ulrike Wittig
(EML Research, Heidelberg, Germany) presented SABIO-
RK, a database of information about biochemical reactions
and enzyme kinetics. The reactions in the database are
mainly taken from the Kyoto Encyclopedia of Genes and
Genomes (KEGG) and the literature, and the kinetic data
comes from the literature. SABIO-RK can be accessed via
both a user interface and web services [http://sabio.villa-
bosch.de/]. Recent improvements include a new data model
for SABIO-RK that allows the storage of intermediate steps
in a reaction, making SABIO-RK the first database to offer
kinetic information for both biochemical reactions and their
individual steps.
DNA synthesis and sequencing comprise one of the
cornerstones of modern biology, and Tuval Ben Yehezkel
(Weizmann Institute, Rehovot, Israel) described new
strategies for synthesizing completely de novo DNA
fragments using single-molecule PCR in a completely
automated fashion. Single-molecule PCR can be readily
scaled up, and will complement the highly parallel DNA
sequencing technologies such 454 and Solexa sequencing in
the future.
Steve Oliver (University of Cambridge, UK) and his
colleagues have taken automation even further, describing
an automated experimental system to study yeast
metabolism. He and colleagues have designed a robot, called
Adam, that uses abductive logic programming (ALP) and is
capable of reasoning about hypotheses and data, designing
experiments to test the hypotheses, and then carrying out
those experiments and interpreting the results.
E Et th hi ic cs s   a an nd d   s se ec cu ur ri it ty y
Scientists in all fields have a duty to consider the public
impact of their work and the conference included a lively
panel discussion covering ethics, public engagement and
biosecurity. Drew Endy (Stanford University, USA) asserted
that while the basics of genetic engineering have not
changed in more than 30 years, synthetic biology is
revolutionary. He raised the question of people trying to
‘hack’ genomes in their garage: how should they be
managed, if indeed they should be managed at all? He also
described how the patent system is flawed with regard to
synthetic biology; for example, patenting the BioBricks
registry of DNA parts encoding basic biological function
would be expensive and counterproductive.
Matthew Harvey (Royal Society, London, UK) cautioned that
we should not assume that the public must be engaged:
sometimes the public simply are not interested. In contrast
to genetically modified organisms, there are no synthetic
biology products queuing up to be sold right now. Therefore,
questioning the public about synthetic biology is currently
less like traditional public engagement and more like social-
intelligence gathering.
Two concerns were discussed by Julian Savulescu (Univer-
sity of Oxford, UK): that synthetic biology may pose risks in
terms of malevolent use, and that the use of synthetic
biology might undermine the moral status of living things.
For regulators, the challenge is to minimize the risk of male-
volent use. For scientists, it is to make better predictions
about how research will be used in the future. For
philosophers, the challenge is to ascertain criteria for moral
status, and determine how to weigh the risk of future
wrongdoing against the benefits of pursuing research in
synthetic biology. Piers Millet (UN Biological Weapons
Convention Implementation Support Unit, Geneva, Switzer-
land) invited scientists to work with security people to
prevent bioterrorism. He highlighted that this engagement
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organization could help.
A new feature for BioSysBio 2009 to extend participation in
the conference was to a wider audience by communicating
live content through microblogging (using FriendFeed and
Twitter; Figure 1) and live blogging (providing an immediate
and permanent log) [http://themindwobbles.wordpress.
com/tag/biosysbio-2009/]. The fields covered by the
conference are still developing. Researchers are opening up
new topics, discovering that mathematical, physical and
engineering concepts apply to ever more biological
problems. The new generation of researchers increasingly
see themselves as forming a new discipline, and while this is
exciting, they must ensure that they do not cut themselves
off from either of the ‘parent’ disciplines, the physical
sciences (including engineering) and the biological sciences;
in particular, more traditional biologists do have important
knowledge to convey and questions to pose. However, the
results reported at the meeting show that, in most cases, the
best from both disciplines is being matched - and exceeded.
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F Fi ig gu ur re e   1 1
Word cloud of the contents of the BioSysBio Twitter feed, identified via the search term “#biosysbio”. The size of each of the words corresponds to
their usage frequency. Image generated using wordle.net by Simon Cockell [http://www.flickr.com/photos/sjcockell/3389493857/]. Licensed under the
Attribution 2.0 Generic License [http://creativecommons.org/licenses/by/2.0/deed.en_GB].